Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Oct 2011. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
66106901000001117 | Mesalazine 1g modified-release tablets 60 tablet (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
66107001000001118 | Mesalazine 1g modified-release tablets 60 tablet | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Pentasa 1g modified-release tablets (Ferring Pharmaceuticals Ltd) 60 tablet 6 x 10 tablets | Is a | True | Mesalazine 1g modified-release tablets 60 tablet | Inferred relationship | Existential restriction modifier | |
Pentasa 1g modified-release tablets (Waymade Healthcare Plc) 60 tablet | Is a | True | Mesalazine 1g modified-release tablets 60 tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets